Although comparisons did not reach statistical significance, the similar outcomes to adjuvantly treated stage III patients suggest that further exploration of neoadjuvant therapy in patients with SBA should continue.
← all excerpts
Natural history and prognostic factors for localised small bowel adenocarcinoma.
1
—
—